Transpire Bio Achieves Important Corporate Milestone With Completion Of First Human Subject Study In The Company’S ...
(MENAFN- GlobeNewsWire - Nasdaq) WESTON, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated, clinical-stage biopharmaceutical company focused on developing inhaled medicines, today announced that the company has completed the first human …